Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ESMO Congress 2026 · Barcelona, Spain
4 shown of 2,600 total abstracts
  1. Abstract LBA4000LBA2026-09-03 · 21:30 CT · Arie Crown Theater
    Opdivo plus chemotherapy in previously untreated metastatic melanoma: updated analysis from CheckMate-479
    T. Mok, E. Winer, H. Borghaei · Royal Marsden Hospital
    Plenary SessionMelanoma📄🖼️
  2. Abstract LBA4001LBA2026-09-03 · 14:30 CT · Arie Crown Theater
    Real-world effectiveness of Opdivo vs standard of care in metastatic melanoma
    H. Rugo, J. Brahmer, M.C. Garassino, et al. · National Cancer Center Japan
    Plenary SessionMelanoma📄🖼️
  3. Abstract LBA4002LBA2026-09-01 · 19:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in metastatic melanoma (the CheckMate-113 study)
    L. Paz-Ares, R. Herbst, H. Borghaei, et al. · MD Anderson Cancer Center
    Plenary SessionMelanoma📄🖼️
  4. Abstract LBA4003LBA2026-09-02 · 19:30 CT · E450
    Long-term follow-up of Opdivo 3L+ for metastatic melanoma: CheckMate-36
    N. Rizvi, S. Modi, C. Saura, et al. · Mayo Clinic
    Plenary SessionMelanoma📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.